Withdrawals due to adverse events · patients with hip osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
Withdrawals due to adverse events · patients with hip osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
Withdrawals due to adverse events · patients with hip osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
Withdrawals due to adverse events · patients with hip osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
Withdrawals due to adverse events · patients with hip osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
Withdrawals due to adverse events · Patients with collagenous colitis
Mesalamine showed no clear difference in withdrawals due to adverse events compared with placebo (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · Patients with collagenous colitis
It is very uncertain whether budesonide changes withdrawals due to adverse events compared with placebo (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · Patients with collagenous colitis
Boswellia serrata extract showed no clear difference in withdrawals due to adverse events compared with placebo (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · Patients with collagenous colitis
Budesonide showed no clear difference in withdrawals due to adverse events compared with mesalazine (low certainty).
1 finding from 1 review
Adverse eventsMeasurement unclear · overweight or obese adults
1 finding from 1 review
Any adverse events ‐ not reported · depression in adults
The review found no eligible studies for this question.
1 finding from 1 review
Any adverse events ‐ not reported · depression in adults
The review found no eligible studies for this question.
1 finding from 1 review
Any adverse events Up to 3 months · patients with depression
Music therapy plus treatment as usual (TAU) showed no clear difference in any adverse events Up to 3 months compared with TAU (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · adults with postherpetic neuralgia
1 finding from 1 review
Adverse events (number of events) · people with acute HBV infection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Short‐term serious adverse events · patients with rheumatoid arthritis
Celecoxib showed no clear difference in short‐term serious adverse events compared with traditional NSAIDs (low certainty).
1 finding from 1 review
Short‐term serious adverse events · patients with rheumatoid arthritis
Celecoxib showed no clear difference in short‐term serious adverse events compared with placebo (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · adults with fibromyalgia
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Withdrawals due to adverse events · adults with fibromyalgia
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Withdrawals due to adverse events · adults with fibromyalgia
1 finding from 1 review
no estimate extracted
Studies not reported
Very low